Company Filing History:
Years Active: 1994-1996
Title: Richard W. Shulman: Innovator in Ophthalmic Solutions
Introduction
Richard W. Shulman is a notable inventor based in New York, NY (US). He has made significant contributions to the field of ophthalmology, particularly through his innovative patents. With a total of 2 patents, Shulman's work focuses on enhancing the treatment of ophthalmic wounds.
Latest Patents
Shulman's latest patents include a fibronectin-containing ophthalmic solution and a method of preserving it. This stable and soluble multi-dose ophthalmic solution contains fibronectin, an amino acid, a sugar, and a lower alkyl p-hydroxybenzoate. The patent also discloses a method for treating ophthalmic wounds using this solution. Additionally, it outlines a process for preparing fibronectin for ophthalmic use, a method for lyophilizing an aqueous solution of fibronectin free of albumin, and a technique for inhibiting bacterial growth in the ophthalmic solution while preserving the cellular adhesion and wound healing activities of fibronectin.
Career Highlights
Throughout his career, Richard W. Shulman has worked with reputable organizations such as the New York Blood Center, Inc. and JCR Pharmaceuticals Co., Ltd. His experience in these institutions has contributed to his expertise in developing innovative solutions for ophthalmic care.
Collaborations
Shulman has collaborated with notable colleagues, including Bernard Horowitz and Adrianne J. Setton. These partnerships have likely enriched his research and development efforts in the field.
Conclusion
Richard W. Shulman's contributions to ophthalmic solutions demonstrate his commitment to advancing medical treatments. His innovative patents reflect a deep understanding of the complexities involved in ophthalmic care.